In this article we show that the paramyxovirus SV5 is a poor inducer of interferon-␤ (IFN-␤). This inefficient induction is a consequence of the expression of an intact viral V protein. In the absence of the viral V protein cysteine-rich C-terminal domain, IFN-␤ mRNA is strongly induced and the transcription factors NF-B and IRF-3 are activated significantly. The V protein can work in isolation from SV5 to block intracellular dsRNA signaling. The mechanism of block to dsRNA signaling is distinct from that previously observed for blocking IFN signaling in that proteolysis of candidate factors cannot be detected, and furthermore, the respective blocks require distinct protein domains. Blocking of the induction of IFN-␤ by dsRNA requires the C-terminal cysteine-rich domain, a feature that is highly conserved among paramyxoviruses. We demonstrate that the V proteins from other paramyxoviruses have equivalent functions and speculate that limiting the yield of IFN-␤ during infection may be a general property of paramyxoviruses.
INTRODUCTION
The type I interferons (IFNs) are secreted polypeptides that act in a pleiotropic manner to limit viral replication and spread (reviewed by Biron and Sen, 2001) . In fibroblastoid cells such as bronchial epithelia the product of the single IFN-␤ gene is directly induced in response to viral infection and IFN-␤ feeds back onto cells in an autocrine fashion to set up a state that permits induction of the multigene IFN-␣ family if infection persists (reviewed by Taniguchi et al., 2001) . Since most viruses are capable of inducing IFN-␤ to some extent, it is generally assumed that the common inducer is intracellular double-stranded RNA (dsRNA) provided by the viral genome itself or formed as a result of replication or convergent transcription of viral genomes (reviewed by Jacobs and Langland, 1996) .
To establish even transient infections in vivo, viruses must be able to evade the IFN response. It is well established that viruses can block the activities of enzymes involved in the IFN response; more recently it has become clear that many viruses block IFN signaling in a variety of ways (reviewed in Goodbourn et al., 2000) . For example, the Rubulavirus genus, including simian virus 5 (SV5) and human parainfluenza virus 2 (hPIV2) of the Paramyxoviridae, directs the proteolytic degradation of members of the STAT family of transcription factors in a species-specific manner. Thus, SV5 infections lead to the degradation of STAT1 in human cells but not in mouse cells (Didcock et al., 1999a,b; Parisien et al., 2002) , whereas hPIV2 infection leads to the degradation of STAT2 in human cells (Young et al., 2000; Parisien et al., 2001; Nishio et al., 2001; Andrejeva et al., 2002) . Other paramyxoviruses, for example the Respirovirus Sendai virus, interfere with IFN signaling without necessarily causing STAT degradation (Young et al., 2000; reviewed in Gotoh et al., 2001) .
Viruses might also evade the IFN system by encoding mechanisms that limit the production of IFN. Although there is only a limited amount of information available on the molecular mechanisms of this process, there appears to be a considerable spectrum in the levels of IFN induced by individual viruses (reviewed in Marcus, 1983 ), suggesting that viruses have evolved mechanisms to at least limit the yield of IFN. In the case of influenza A virus, the NS1 protein may play such a role. This protein is a dsRNA-binding protein that may limit the amount of inducer presented to the cell; thus NS1 can block activation of NF-B by synthetic dsRNA (Wang et al., 2000) , while an influenza strain lacking the NS1 gene induces NF-B, IRF-3, and IFN-␤ (Talon et al., 2000) .
The induction of IFN-␤ expression by viral infection has been the subject of intensive research and occurs primarily at the level of transcriptional initiation. The IFN-␤ promoter consists of four positive regulatory domains (PRDs) that contribute to the magnitude of induction with each PRD being the target for a distinct, inde-pendently activated, transcription factor (reviewed in Goodbourn et al., 2000; see Fig. 3A) . PRD II is bound and activated by NF-B (Lenardo et al., 1989; Visvanathan and Goodbourn, 1989 ) and PRD IV is bound and activated by either ATF-2 homodimers or a heterodimer of ATF-2/c-Jun (Du and Maniatis, 1992; Du et al., 1993) . The situation with PRD I and PRD III is more complicated; these elements are related at the DNA sequence level and both bind to members of the interferon regulatory factor (IRF) family. It remains unclear whether activation through PRD I/PRD III is restricted to a specific IRF protein, but recent observations indicate that IRF-3 activation is especially important (Juang et al., 1998; Ronco et al., 1998; Sato et al., 1998; Schafer et al., 1998; Wathelet et al., 1998; Weaver et al., 1998; Yoneyama et al., 1998) . The individually activated transcription factors that bind to PRDs I-IV are assembled in a cooperative manner on the IFN-␤ promoter in a multiprotein complex, called the enhanceosome, that also includes the "architectural factor" HMG-I:Y (reviewed by Merika and Thanos, 2001) .
The signaling pathways between the detection of intracellular dsRNA and the activation of transcription factors are poorly understood, although it is established that the dsRNA-dependent protein kinase (PKR) plays an important role (reviewed by Williams, 2001) . PKR activates the IKK␤ subunit of the multicomponent IB kinase (Chu et al., 1999; Zamanian-Daryoush et al., 2000) in a manner that may not require the PKR catalytic activity (Ishii et al., 2001) ; IB kinase phosphorylates IB, which in turn becomes ubiquitinated by an E3 ubiquitin ligase and targeted to proteasomes for degradation. Once the inhibitory IB is destroyed, the associated NF-B is freed from restraint and can enter the nucleus and activate transcription (reviewed in Israel, 2000) . Activation of PKR is also important in the rise in IRF-1 levels that are seen in response to viral infection or exposure to synthetic dsRNA (Kumar et al., 1997) , and in the activation of the PRD IV-binding ATF-2 complexes through the intermediacy of MAP kinases (Chu et al., 1999; Iordanov et al., 2000b) . However, it has recently been shown that NF-B may also be activated in response to dsRNA by an uncharacterized PKR-independent pathway (Iordanov et al., 2000a) . Thus there may be at least two distinct intracellular dsRNA signaling pathways. Furthermore, although the relocalization of IRF-3 from the cytoplasm to the nucleus in response to viral infection or synthetic dsRNA requires a cellular kinase, current experimental data are consistent with this kinase being something other than PKR (Smith et al., 2001; Servant et al., 2001) .
In this article we show that the product of the V gene of SV5 plays an essential role in limiting the induction of IFN-␤ mRNA during viral infection. A recombinant SV5 virus that expresses a V protein lacking the unique Cterminus induces significant levels of IFN-␤ mRNA and activates NF-B and IRF-3. These proteins are not de-graded during infection by wild-type SV5, and hence, the product of the V gene can affect both arms of the IFNmediated innate immune response using distinct mechanisms. Unlike the targeted degradation of STAT1 which requires both N-and C-terminal epitopes, only the cysteine-rich region of the V protein is required to block dsRNA signaling. This region is highly conserved among paramyxoviruses, and we show that the V gene products of hPIV2 and Sendai virus also block IFN-␤ induction; these observations suggest that limiting the yield of IFN-␤ during infection may be a general property of paramyxoviruses.
RESULTS

Efficient induction of IFN-␤ by SV5 lacking the C-terminus of the V protein
We have reported previously that SV5 infection induces the expression of IFN-␤ in mouse and human cell lines (Didcock et al., 1999a) . To assess the relative efficiency of induction by SV5 with that of other known inducers, we examined the production of IFN-␤ mRNA in a number of cell lines. Figure 1A shows an experiment performed using MG-63 cells (a human osteosarcoma cell line widely used as a potent IFN-␤ producer). Although wild-type (wt) SV5 (W3)-infection induces IFN-␤ mRNA, the levels produced even under optimum conditions [multiplicity of infection (m.o.i.) ϭ 5, 18 h postinfection (p.i.); Lanes 1 to 4] are barely detectable in comparison to that seen by the addition of the synthetic dsRNA [poly(I)-poly(C)] to the culture medium (Lane 7). To compare induction of IFN-␤ by wt SV5 (W3) with well-characterized inducers, we analyzed the behavior of Sendai virus and Newcastle disease virus (NDV) in MG-63 cells. Figure 1A (Lanes 8 and 9) shows that both of these viruses induce IFN-␤ at least as well as poly(I)-poly(C) and considerably better than SV5 at the same input m.o.i. The Sendai virus stock used in the experiment shown in Lane 9 was prepared by inoculation of 10-day-old embryonated chickens eggs with a high dilution of viral stock. However, the efficient induction of IFN-␤ normally observed with Sendai virus is associated with DI particles that are generated by serial passage in embryonated chicken eggs at low dilutions (von Magnus, 1951a,b; Johnston, 1981) . When Sendai virus was prepared in this way, the induction of IFN-␤ was considerably greater than the high dilution inoculum stock of Sendai virus at an equivalent m.o.i. (Fig. 1A , compare Lanes 10 and 9). The relatively poor induction by SV5 in comparison to dsRNA, NDV, and the optimized Sendai virus preparation was also seen in human fibroblast 2fTGH cells, human embryonic kidney (293) cells, or mouse BALB/c cells (data not shown). These results indicate that SV5 and certain stocks of Sendai virus are intrinsically poor inducers of IFN-␤ in human fibroblastoid cell lines.
Since we had previously shown that the V protein of SV5 was capable of blocking signaling in response to IFN (Didcock et al., 1999b) , we next investigated whether SV5 engineered to express a V gene product that is truncated so as to lack the C-terminal cysteine-rich domain (rSV5V⌬C-see accompanying article, He et al., 2002) was able to induce IFN-␤ more efficiently than wild-type SV5. Figure 1B shows that infection of MG-63 cells with the W3 strain of SV5 causes a weak induction of IFN-␤ mRNA that is barely detectable at 18 h p.i. (Lanes 1-4); by contrast, infection with rSV5V⌬C at an equivalent m.o.i. strongly induces IFN-␤ mRNA at the earliest time point examined (12 h p.i.; Fig. 1B , Lanes 5-7). A similarly enhanced induction of IFN-␤ mRNA by rSV5V⌬C relative to the W3 strain was seen in human 2fTGH cells (see Fig. 2A ) and mouse BALB/c cells (data not shown). These data indicate that SV5 which lacks an intact V protein either produces an inducer of IFN-␤ not made by the wild-type virus and/or that the SV5 V protein is a potent inhibitor of IFN-␤ mRNA induction. It is also noteworthy that unlike the species-specificity of the SV5 V protein with respect to blocking IFN signaling (Didcock et al., 1999b; Young et al., 2001; Parisien et al., 2002) expression of the intact SV5 V protein limits the production of IFN-␤ mRNA in both human and mouse cells.
We previously reported important differences in the ability of two closely related canine isolates of SV5, termed CPIϩ and CPIϪ, to block IFN signaling (Chatziandreou et al., 2002) . CPIϩ blocks IFN signaling by targeting STAT1 for degradation, whereas CPIϪ does not; this difference is the result of three amino acid substitutions in the common V/P N-terminal domain. Although these viruses exhibit indistinguishable growth in cells that cannot produce type I IFN it would be expected that in cells that can produce IFN, the replication of the CPIϪ strain would be impaired as a result of IFN sensitivity. Surprisingly, we found that CPIϪ infections were only cleared slowly in the latter unless the cells were treated with type I IFN (CPIϩ infections which block IFN responses were resistant to exogenous IFN; Chatziandreou et al., 2002) . These results can be explained if CPIϪ and CPIϩ strains are poor IFN-␤ inducers. To test this directly, we compared the IFN-␤ induction profile by CPIϪ and CPIϩ. Figure 1C shows that both CPIϪ (Lanes 5-7) and CPIϩ (Lanes 8-10) are poor inducers in MG-63 cells when compared to rSV5V⌬C (Lane 12), NDV, and the optimized Sendai virus preparation (data not shown), although they are slightly more efficient inducers than SV5 W3 (Lanes 2-4). The fact that little or no difference is seen in the early phase of IFN-␤ induction by CPIϪ and CPIϩ shows that the substitutions in the CPI V protein that alter the ability to block IFN signaling are distinguishable from V protein functions that block IFN-␤ induction. It is interesting to note that at later periods in infection (21 h p.i.), CPIϪ begins to become a better inducer than CPIϩ (Fig. 1C , compare Lanes 7 and 10). Although IFN-␤ induction occurs without the need for de novo protein synthesis, the yield is enhanced by a positive autoregulation loop that can involve the activation of ISGF3 or IRF-1 by IFN (Yoneyama et al., 1996) , or the induction of synthesis of IRF-7, which is subsequently activated by viral infection (reviewed by Taniguchi et al., 2001) . The ability of the CPIϩ virus to block IFN signaling would prevent this virus from showing the amplification of IFN-␤ production seen with CPIϪ and thus produce the observed differences at later time points.
Limited amounts of the V protein of SV5 (ϳ350 molecules) enter the target cell as part of the virion (Paterson et al., 1995) . We were therefore interested to see whether small amounts of SV5 V protein would be sufficient to block IFN-␤ induction, as seen for the degradation of STAT1 and the inhibition of IFN signaling, and whether the induction of IFN-␤ seen in rSV5V⌬C-infected cells could be blocked by expressing the V protein in trans. Coinfection of 2fTGH cells by wt SV5 (W3) and rSV5V⌬C did not lead to a suppression of IFN-␤ induction ( Fig. 2A , Lanes 1-6), perhaps suggesting that the V protein cannot work in trans, or that rSV5V⌬C induces IFN-␤ sufficiently fast enough that the limited amount of V protein entering the cells in wt SV5 (W3) virions is unable to block the cellular response to SV5 infection. We next infected a 2fTGH cell line that stably expresses the V protein of SV5 (which blocks IFN signaling in these cells) (Andrejeva et , and a derivative that stably expresses the SV5 V protein (Lanes 7-12) were infected with SV5 (W3) or rSV5V⌬C (V⌬C) at an m.o.i. of 5, or a mixture of W3 and rSV5V⌬C at the indicated ratios and a total m.o.i. of 5 for 18 h, and the IFN-␤ mRNA levels determined by RNase mapping. The mobilities of the IFN-␤ and ␥-actin transcripts (internal control) are indicated to the right of each panel. (B) Vero cells were transfected with a reporter for IFN-␤ promoter activity [pIF⌬(-125)lucter-see Materials and Methods], the ␤-galactosidase expression vector, pJATlac, and either a mammalian expression plasmid driving the overexpression of the SV5 V protein or a control "empty vector." Transfected cells were infected with either SV5 (W3) or rSV5V⌬C (V⌬C) at an m.o.i. of 5 for 18 h and then cell extracts were prepared for reporter gene assays. In each case luciferase activity was corrected to the ␤-galactosidase activity to normalize for variations in the transfection efficiency. Transfection experiments were repeated at least three times and averages and error bars are shown. Expression levels are relative to the rSV5V⌬C-infected level of the Ϫ125 construct (ϭ1.0). (C) Vero cells were transfected with either pIF⌬(Ϫ125)lucter as a reporter for IFN-␤ promoter activity or a reporter for type I IFN responsiveness [p(9-27ISRE) 4 tk⌬(Ϫ39)lucter], the ␤-galactosidase expression vector, pJATlac, and a mixture of a mammalian expression plasmid driving the overexpression of the SV5 V protein and the control empty vector such that the total amount of effector plasmid was kept constant: The amount of SV5 V expressing plasmid in each transfection is indicated on the x-axis in nanograms. IFN responsiveness was determined by treating cells for 5 h with 1000 IU/ml of IFN. Responsiveness to rSV5V⌬C (V⌬C) was determined by infecting cells an m.o.i. of 5 for 18 h. In each case luciferase activity was corrected to the ␤-galactosidase activity to normalize for variations in the transfection efficiency. The inducibilities of the reporters in transfections with no SV5 V expressing plasmid were determined for IFN and rSV5V⌬C (V⌬C), respectively, and set at 100%; samples from transfections containing SV5 V protein expressing plasmids are given in percentage maximum inducibility compared to this control. Transfection experiments were performed twice and averages and error bars are shown.
al., 2002) with the rSV5V⌬C virus. Figure 2A shows that these cells are unable to block IFN-␤ induction by rSV5V⌬C infection. The SV5 V protein expressing stable cell lines are characterized by levels that are at least 20-fold lower than that achieved during a viral infection , and we note that we have not succeeded in constructing cell lines that express high levels of SV5 V protein, suggesting that this may be toxic to host cells. To determine whether highlevel V protein expression is capable of blocking IFN-␤ induction by SV5, we examined the ability of overexpressed SV5 V protein to block induction by rSV5V⌬C infection of a luciferase reporter gene under the control of an IFN-␤ promoter in transient transfections. Figure 2B shows that induction is significantly inhibited, indicating that the viral V protein can act in trans to block induction if expressed to adequate levels. To test further whether the respective blocks to IFN signaling and IFN induction are differentially sensitive to expression levels of the SV5 V protein, we compared the effects of increasing levels of a plasmid expressing SV5 V on the relative inducibilities of an ISRE reporter by IFN, and of an IFN-␤ promoter reporter by rSV5V⌬C infection. Figure 2C shows that SV5 V expression inhibits IFN responses by more than 90% even at the lowest levels tested, whereas inhibition of induction of the IFN-␤ promoter reporter by rSV5V⌬C was barely evident at these levels and required higher levels of expression to achieve a block of greater than 50%. These data suggest that the block to IFN signaling and the block to IFN-␤ induction are mechanistically distinct.
NF-B and IRF-3 activation by SV5 lacking full-length V gene product
Induction of IFN-␤ by viral infection requires the activation of distinct transcription factors, with considerable evidence supporting the importance of NF-B and members of the IRF family as the key transcription factors (see Introduction). To establish the requirement for these factors for induction of IFN-␤ by rSV5V⌬C and to determine whether the failure of wt SV5 (W3) to induce IFN-␤ expression could be linked to a defect in activation of one of these factors or the failure to activate several transcription factors, we transiently transfected a series of luciferase reporter constructs under the control of the human IFN-␤ promoter and mutant derivatives and examined their inducibility by viral infection. The constructs used in this analysis are shown in Fig. 3A . Figure 3B shows that deletion from the 5Ј end of the IFN-␤ promoter had only a limited effect on induction by rSV5V⌬C until nucleotide Ϫ98 was removed; these results demonstrate that the HMGI:Y binding sequence (TAAAT) located at residues Ϫ102 to Ϫ98 (Du et al., 1993) is not required for induction of IFN-␤ by rSV5V⌬C, in agreement with our previous observations on induction by poly(I)⅐poly(C) (Ellis and Goodbourn, 1994; King and Goodbourn, 1994) . Further deletion from the 5Ј end of the IFN-␤ promoter led to a stepwise loss in inducibility with removal of the PRD III, PRD I, and PRD II elements. None of these constructs were responsive to wt SV5 (W3) infection (data not shown). To evaluate the individual contribution of the PRD elements, we examined the inducibility of reporter constructs under the control of the IFN-␤ promoter containing linker scan mutations. Figure  3B shows that disruption of any of the four PRD elements severely impairs induction by rSV5V⌬C. Since each of the individual PRD elements has been shown to be independently inducible in certain cell/inducer combinations, we tested the responsiveness of reporter constructs containing multimers of either PRD IV, PRD III/ PRD I, or PRD II placed upstream of a minimal HSV-1 thymidine kinase TATA box. Figure 3C shows that the NF-B-responsive PRD II construct and the IRF-responsive PRD I/PRD III construct respond dramatically to infection by rSV5V⌬C, whereas expression driven by the PRD IV construct is not responsive. Taken together, the insensitivity to deletion of the HMGI:Y site between Ϫ103 and Ϫ97 and the lack of inducibility of the PRD IV reporter construct demonstrate that activation of the ATF-2-c-Jun/HMGI:Y module (Du and Maniatis, 1992; Du et al., 1993) is unimportant for IFN-␤ induction by rSV5V⌬C, and we have not considered it further.
In contrast to the induction of both the PRD II and the PRD I/III reporters by rSV5V⌬C, neither reporter is activated by wt SV5 (W3) infection ( Fig. 3C ), suggesting that infection by wt SV5 (W3) virus fails to activate a signaling pathway that is common to the induction of factors that stimulate transcription through the unrelated PRD II and PRD I/III elements. Consistent with this, the overexpression of the SV5 V protein significantly diminishes the induction of both reporters by rSV5V⌬C ( Fig. 3C) .
Although the PRD I/III site of the IFN-␤ promoter can bind to several members of the IRF family, it is believed that IRF-3 activation plays a key role in IFN-␤ induction in response to viral infection (see Introduction). To test whether IRF-3 activation plays a role in IFN-␤ induction by rSV5V⌬C, we examined the effect of expressing a dominant-interfering form of IRF-3 . Figure 3D shows that induction by rSV5V⌬C is completely abolished in the presence of the interfering form of IRF-3. To examine the behavior of IRF-3 in isolation from other members of the IRF family, we constructed a fusion to the bacterial DNA-binding protein, lexA, and examined the ability of this fusion to stimulate transcription from a luciferase reporter gene under the control of a lexA operator site. Figure 3E shows that this construct is responsive to infection by rSV5V⌬C [but not by infection by wt SV5 (W3)-data not shown]. The induction in response to rSV5V⌬C is significantly inhibited by the coexpression of the SV5 V protein (Fig. 3E) . These data show that IRF-3 activation is required for IFN-␤ induction by rSV5V⌬C and that the activation of IRF-3 can be blocked by the SV5 V protein.
The data above suggest that NF-B and IRF-3 are the key transcription factors involved in IFN-␤ induction in response to rSV5V⌬C infection; these factors are not induced in the presence of the full-length V protein expressed during either a wild-type infection or expressed in trans during infection by rSV5V⌬C. We have confirmed the activation of both NF-B and IRF-3 by rSV5V⌬C infection, but not wt SV5 (W3) infection, by gel-retardation assays and immunofluorescence experiments; also note that rSV5V⌬C infection leads (indirectly) to IRF-1 production and ISGF3 activation (He et al., 2002 and data not shown). The failure of wt SV5 (W3) infection to activate these responses could be due to a virally induced degradation of transcription factors in a manner analogous to the degradation of STAT1. Western blot analysis using antibodies specific for either the p65 or the p50 subunits of NF-B subunit, or for IRF-3, demonstrated that neither of these proteins are targeted for degradation by SV5 infection, in contrast to the consequences of SV5 infection on STAT1 (Fig. 4) .
The V protein of SV5 can block the induction of IFN-␤ by dsRNA
The difference in the IFN-inducing properties of wildtype SV5 (W3) and rSV5V⌬C could be due either to the V product having a specific function that directly blocks IFN-␤ production or to an indirect effect such that the viruses have different innate IFN inducing capacities; for example, rSV5V⌬C infections could generate more intracellular dsRNA than wt SV5 (W3). To distinguish these possibilities, we investigated whether overexpression of the SV5 V protein could block induction by synthetic dsRNA of a luciferase reporter gene under the control of an intact IFN-␤ promoter in transient transfections. Figure 5A shows that SV5 V protein expression can limit induction of the IFN-␤ promoter by about 90%; we performed similar experiments in 293 cells and obtained a similar inhibition of IFN-␤ induction by the SV5 V protein (Fig. 5B ). In addition to the ability of the SV5 V protein to block dsRNA induction of the IFN-␤ promoter, blockage was also seen in response to Sendai virus infection (Fig.  5C ). Since dsRNA can activate individual transcription factors that are involved in IFN-␤ induction, we examined the ability of the SV5 V protein to block NF-B induction by dsRNA. Figure 5D shows that the induction of reporter activity by dsRNA is down-regulated by about 80% when cells were cotransfected with the SV5 V protein expressing plasmid; by contrast, we observed a small but reproducible enhancement of induction by an alternative NF-B inducer, TNF␣ (Fig. 5E ). These data indicate that the SV5 V protein can block intracellular dsRNA signaling in the absence of other viral products.
Inhibition of induction of IFN-␤ by SV5 V protein is a property of the cysteine-rich C-terminus
To map the regions of the SV5 V protein that block the induction of IFN-␤ by synthetic dsRNA, we first determined whether the viral polymerase P protein had similar properties, as the V and P proteins share 164 N-terminal residues. As shown in Fig. 6A the SV5 P protein is unable to block the induction of IFN-␤ by synthetic dsRNA. Thus, these data indicate that the unique cysteine-rich C-terminus of V plays an important role in this process.
A panel of mutations in the SV5 V gene was constructed and the effect of expression of these proteins on IFN-␤ induction by dsRNA was examined. As shown in Fig. 6B deletion of N-terminal sequences up to amino acid 125 had no effect on inhibition. Deletion of the C-terminal 48 amino acids inactivated the inhibition, indicating that the C-terminal region of the protein is important for blocking IFN-␤ induction, in contrast to the block to IFN signaling which requires sequences at the N-terminus as well as the C-terminus (Young et al., 2001; Chatziandreou et al., 2002; Andrejeva et al., in press ).
The C-terminal region of the SV5 V protein is characterized by the presence of several cysteine residues. To investigate the importance of these cysteine residues in blocking IFN-␤ induction, we changed several of them by site-directed mutagenesis, cloned the mutant genes into a mammalian expression vector, and then examined their effects in response to synthetic dsRNA. As shown in Fig. 6C changes at cysteines 193, 207, and 214 individually inactivated the ability of the viral V protein to block dsRNA signaling, despite the proteins being expressed at equivalent levels as assessed by immunofluorescence (data not shown). These data show that inhibition of induction of IFN-␤ requires a cysteine-rich region of no more than 97 amino acids (amino acids 126 to 222) at the C-terminal end of the SV5 V protein.
Inhibition of induction of IFN-␤ is a property of other paramyxovirus V proteins
The importance of the cysteine-rich C-terminus of SV5 in blocking the induction of IFN-␤ is particularly interesting since this region is the most conserved domain among V proteins of other Paramyxovirinae, including viruses from all three genera, Respiroviruses, Rubulaviruses, and Morbilliviruses. To investigate whether V proteins from viruses other than SV5 could block IFN-␤ induction, we constructed mammalian expression vectors for the V proteins of hPIV2 and Sendai virus. Both of these constructs blocked IFN-␤ induction by dsRNA to an equivalent extent to the V protein of wt SV5 (W3) (Fig.  7) . We also examined the properties of V proteins of distinct isolates of SV5. Figure 7 shows that an N100D change (from a virulent mouse-adapted strain) (Young et al., 2001) , and the limited substitutions observed in the CPIϩ and CPIϪ strains (Chatziandreou et al., 2002) had no effect on the blockage to IFN-␤ induction by dsRNA; these results were expected since these amino acid changes lie outside of the conserved cysteine-rich Cterminus.
DISCUSSION
We have reported previously that the V protein of SV5 plays an essential role in evading the IFN system by targeting the host cells STAT1 protein for proteosomal degradation (Didcock et al., 1999b) . Similar results have been reported for the V protein of hPIV2, except that STAT2 is preferentially degraded (Parisien et al., 2001; Nishio et al., 2001; Andrejeva et al., 2002) . In this article, we show that the V protein of SV5 has an additional distinct effect on the IFN system, namely that of acting to minimize the yield of IFN-␤ produced by an infected cell. While this property is dispensable for growth in Vero cells that cannot produce IFN, it appears to be essential for efficient growth in other cell lines in which the IFN system is intact (see He et al., 2002) ; consistent with this revertants are generated at high frequency during passage of the SV5V⌬C mutant virus. Since the SV5 V protein blocks transcriptional activation of the IFN-␤ gene by dsRNA, it is also probable that the direct viral activation (i.e., through the production of dsRNA) of other genes FIG. 6. The C-terminal cysteine-rich region of the SV5 V protein is essential for blocking dsRNA signaling. (A) Vero cells were transfected with pIF⌬(Ϫ125)lucter, pJATlac, and either a mammalian expression plasmid driving the overexpression of SV5 V protein, a mammalian expression plasmid driving the overexpression of SV5 P protein, or the control empty vector. Transfected cells were either mock-treated or treated with poly(I)-poly(C) (dsRNA) and cell extracts prepared. (B) and (C) Vero cells were transfected with pIF⌬(Ϫ125)lucter, pJATlac, and either a mammalian expression plasmid driving the overexpression of wt or mutant forms of SV5 V protein (see table at the left of figure), or the control empty vector. Transfected cells were either mock-treated or treated with poly(I)-poly(C) (dsRNA) and cell extracts prepared. For each of (A)-(C) luciferase and ␤-galactosidase activities were determined from cellular extracts and relative expression values calculated accordingly (expressed relative to the induced level of the vector-only sample ϭ 1.0). Transfection experiments were repeated at least three times and averages with error bars are shown. involved in the antiviral response, such as Mx, are also blocked.
Our analysis of the V proteins of hPIV2 and Sendai virus show that they also block induction of IFN-␤, and since the domain that is required for blockage by the SV5 V protein is the C-terminal cysteine-rich domain that is highly conserved among paramyxoviruses, we think it likely that the ability to block IFN-␤ production may be a general property of paramyxovirus V proteins. Indeed, this property may be a requirement for efficient growth in the face of a functional IFN system. The V protein is often described as a "luxury function" in that it is not required for growth in culture for rinderpest (Baron and Barrett, 2000) , Sendai virus (Delenda et al., 1997 (Delenda et al., , 1998 , or measles virus (Schneider et al., 1997) . Nevertheless, pathogenicity has been shown to be impaired for Sendai virus (Kato et al., 1997a,b; Huang et al., 2000) or measles virus (Tober et al., 1998; Valsamatis et al., 1998; Mrkic et al., 2000; Patterson et al., 2000) lacking an intact V protein and we speculate that this is at least in part due to the loss of ability to block IFN production. It is interesting to note that measles virus has been shown to block IFN production (Naniche et al., 2000) , although this property has yet to be ascribed to the V protein.
Although the V proteins of the Rubulaviruses have the ability to block both the induction of IFN and the downstream signaling in response to IFN, this function has been separated in the Respirovirus, Sendai virus (Garcin et al., 1999; reviewed in Gotoh et al., 2001) . Thus the C protein(s) of Sendai virus is responsible for blocking IFN signaling, while the V protein blocks IFN induction. Nevertheless, the fact that both Rubulavirus and Respirovirus genera of paramyxoviruses have acquired the ability to block both arms of the IFN system demonstrates the importance of avoiding this aspect of innate immunity to establish a productive infection. It should be emphasized that the blocks are probably operating at different stages during the course of an infection. We have shown previously that although SV5 can degrade the antiviral state established in a cell by previous exposure to IFN (Didcock et al., 1999b) , this process takes several hours and hence the rate of viral spread would be much enhanced if IFN production was limited during the first round of viral infection.
The role of the V protein in limiting the yield of IFN could act in two fundamentally distinct ways. First, it could act to limit the generation of an inducer produced during the viral lifecycle. Second, the V protein could act to prevent the downstream action of a virally generated inducer. Since the V protein can inhibit the signaling response to synthetic dsRNA in activating NF-B, this second role for the V protein would appear to be of major importance. However, we are struck by our observation that none of the paramyxovirus V proteins we have examined are capable of inhibiting the induction of IFN-␤ by dsRNA more than 80-90%. This contrasts with the extremely limited induction of IFN-␤ in the context of viral infection, where wt SV5 (W3) (which expresses a wt V protein) barely induces IFN-␤ in any cell line tested (less than 1% of the levels seen in rSV5V⌬C infections), strongly suggesting that a function of the V protein (e.g., in the control of transcription or replication-see below) also limits the generation of the viral inducer of IFN. This is consistent with our observations that inhibition of dsRNA signaling requires significant levels of V protein expression that might only be achieved relatively late in viral infection and perhaps after the start of generation of the viral signal.
This virally induced signal could be dsRNA, produced during the viral lifecycle. It is well established that V proteins help to regulate viral replication. Sendai virus deficient in V protein synthesis shows increased antigenome synthesis and transcription (Kato et al., 1997a) , and expression of the V protein decreased replication by 60-70% in a Sendai virus DI RNA assay (Curran et al., 1991) , suggesting that V protein may negatively regulate viral replication. Studies on rinderpest virus lacking expression of the V protein show a rise in synthesis of genome and antigenome RNAs, as well as an increase in the cytopathic effect (Baron and Barrett, 2000) . Although a role for the SV5 V protein in regulating RNA replication has not been shown, the SV5 V protein is known to have many functions. The shared N-terminal domain of V and P proteins binds single-stranded RNA through a basic region (Lin et al., 1997) and the SV5 V protein interacts with soluble but not polymeric NP protein and thus may act as a chaperone to keep NP soluble prior to encapsidation of vRNA (Randall and Bermingham, 1996) . Taken together these observations suggest that the V protein may perhaps indirectly limit viral dsRNA levels. It is also possible that the virally induced signal could be some component of the viral lifecycle other than dsRNA. In this context, a recent article suggesting that the measles N gene product can function as an activator of IRF-3 (tenOever et al., 2002) is particularly interesting. The interaction of SV5 V protein with NP might inhibit an equivalent activation by IRF-3.
The target for the V protein in blocking dsRNA signaling is not known. An obvious target would be the dsRNAdependent protein kinase, PKR. This enzyme has been shown to be important for the activation of NF-B by dsRNA (Yang et al., 1995; Kumar et al., 1997) , although recent results suggest that there is a second PKR-independent pathway (Abraham et al., 1999; Iordanov et al., 2000a) . Our observation that the V protein cannot block dsRNA signaling completely may reflect expression levels, or it may reflect the possibility that the V protein can only block one of the alternative dsRNA signaling pathways. It is also unclear whether PKR can function as an upstream kinase for IRF-3 activation; although IRF-3 nuclear translocation in response to either Sendai virus or NDV is not dependent upon PKR (Servant et al., 2001; Smith et al., 2001) , it is not clear whether PKR can perform this function in a redundant pathway. Since the SV5 V protein can block activation of both NF-B and IRF-3, it promises to be a useful reagent for analyzing signaling events that occur during paramyxovirus and other viral infections.
MATERIALS AND METHODS
Plasmids
The reporter plasmids with the firefly luciferase gene under the control of the human IFN-␤ promoter, pIF⌬(Ϫ125)lucter and the 5Ј deletion mutants, pIF⌬(Ϫ116)lucter, pIF⌬(Ϫ103)lucter, pIF⌬(Ϫ98)lucter, pIF⌬(Ϫ97)lucter, pIF⌬(Ϫ92)lucter, pIF⌬(Ϫ82)lucter, pIF⌬(Ϫ78)lucter, and pIF⌬(Ϫ70)lucter have been previously described (King and Goodbourn, 1994) . The linker scan mutants were constructed by generating a series of 3Ј deletion mutants flanked by BglII linkers starting from the NcoI site in the human IFN-␤ promoter of pIF⌬(Ϫ116)lucter at Ϫ12 using the method of King and Goodbourn (1992) . These mutants were characterized by sequencing and then recombined via their BglII linkers with the appropriate 5Ј deletion mutants from our extensive collection (King and Goodbourn, 1992) . The synthetic PRD multimer reporters, p(PRD IV) 3 tk⌬(Ϫ39)lucter, p(PRD I/PRD III) 5 tk⌬(Ϫ39)lucter and p(PRD II) 5 tk⌬(Ϫ39)lucter, the IFN-responsive ISRE reporter p(9-27ISRE) 4 tk⌬(Ϫ39)lucter, and the TK TATA only reporter, ptk⌬(Ϫ39)lucter, have been previously described (Vis-vanathan and Goodbourn, 1989; Goodbourn, 1994, 1998) as has the constitutive ␤-galactosidase transfection control reporter plasmid, pJATlac (Masson et al., 1992) . The lex-responsive luciferase reporter, p(lexOP) 2 TK⌬(Ϫ105)luc, was a kind gift of Dr. Richard Treisman (Cancer Research, U.K.).
All expression in mammalian cells was achieved by subcloning into pEF.plink2 (Dr. Richard Treisman, Cancer Research, U.K.), a vector in which the test transcript is placed under the control of the mammalian EF1␣ promoter. The plasmids directing the expression of the V or P proteins of SV5, pEF.SV5-V, and pEF.SV5-P have been previously described (Didcock et al., 1999b) . Equivalent plasmids expressing the V genes of hPIV2, CPIϪ, CPIϩ, mci-2 (Young et al., 2001) , and Sendai virus were obtained using the same strategy [plasmids pEF.hPIV2-V, pEF.SV5-V(CPIϪ), pEF.SV5-V(CPIϩ), pEF.SV5-V(mci-2), and pEF.SeV-V, respectively]. pEFϪ plasmids directing the expression of C-terminal truncations of SV5 V protein were obtained by cloning NcoI-PstI . All V mutated genes were sequenced (Lark Technologies) and a double-mutant pEF.SV5-V[C193Y/C214A] was obtained as a by-product of one of the mutagenesis experiments. The lexA DBD vector, pEF.mlexA, was constructed by recombinant PCR so as to obtain a DNAbinding-domain fragment (amino acids 1 to 202) of the bacterial lexA transcription factor containing a mutation in the cryptic nuclear localization sequence (Rhee et al., 2000) and inserted into the NcoI site of pEF.plink2. The full-length ORF of IRF-3 flanked by NcoI (5Ј) and XbaI (3Ј) sites was obtained from MG-63 osteosarcoma cells by RT-PCR and was cloned in-frame to the lexA DBD of pEF.mlexA to give pEF.mlexA.IRF-3. The full-length cDNA of IRF-3 was also used to generate the C-terminal dominant interfering form of IRF-3 by subcloning the ScaI-XbaI fragment in-frame with the polylinker of pEF.plink2 to give pEF. .
Viruses and cells
The W3 strain of SV5 (Choppin, 1964) , rSV5V⌬C (see accompanying article, He et al., 2002) , N100D (Young et al., 2001) , and canine parainfluenza virus strains, CPIϩ and CPIϪ (Chatziandreou et al., 2002) , were propagated and titered in Vero cells. Sendai virus (strain Z) and NDV (Ulster 2c strain) were a kind gift from Dr. J. W. McCauley (Institute of Animal Health, Compton, U.K.) and were prepared by inoculation of 10-day-old embryonated chickens eggs with a high dilution of viral stock, followed by 48 h incubation at 35°C. The efficient IFN-␤ inducer stock of Sendai virus used in Fig. 1A was prepared by three serial passages of the above Sendai virus stock at a 1:10 dilution each passage (von Magnus, 1951a,b) . Viral titers for Sendai virus and NDV were established by egg-infectious dose.
MG-63 human osteosarcoma cells (ATCC CRL 1427), human diploid fibroblast 2fTGH cells (Pelligrini et al., 1989) , 2fTGH/V cells , 293 transformed primary human embryonic kidney cells (ATCC CRL 1573), and mouse BALB/c cells (ATCC CCL 163) were maintained in Dulbecco's modified Eagle's medium (Biowhittaker Europe) supplemented with 10% fetal bovine serum (FBS; Invitrogen) and 100 U/ml penicillin/ streptomycin and were routinely screened for mycoplasma contamination.
Inductions
Six-well dishes containing in excess of 10 6 cells per well (determined by trypan blue exclusion) were washed twice with PBS and then inoculated with virus at the given multiplicity of infection in 1 ml of DME ϩ 2% FBS. Cells were incubated with gentle rocking for 1 h at 37°C and then the virus was removed and the medium replaced with 5 ml DME ϩ 2% FBS until harvesting. Cells were either harvested for RNA analysis by acid-phenol/ guanidinium isothiocyanate extraction or were scraped into 1 ml ice-cold PBS and pelleted for nuclear extract preparation. For induction by synthetic dsRNA, poly(I)poly(C) (Amersham Biosciences) was either added directly to cells at a final concentration of 100 g/ml or was transfected into cells using Lipofectamine (Invitrogen) under conditions specified by the manufacturer. TNF␣ (Preprotech) was added to cells at 10 ng/ml. Type I IFN (Intron A; Schering-Plough) was added to cells at 1000 IU/ml.
Protein analysis
To analyze protein levels by Western blotting, cells were washed twice with PBS, disrupted into Laemmli's loading buffer, sonicated, and boiled for 5 min. Polypeptides were separated by SDS-PAGE using 10% gels and transferred to PVDF membranes using semidry blotting. Filters were blocked and incubated with primary antibody under conditions specified by the manufacturers, and proteins detected by enhanced chemiluminescence using horseradish peroxidase conjugated sheep antimouse or donkey anti-rabbit IgG (Amersham Bio-sciences) as secondary antibodies. Primary antibodies used were as follows: SV5 P/V protein-anti-Pk mAb (Randall et al., 1987) ; p65 and p50 (Mellits et al., 1993) ; IRF-3 (Santa Cruz Biotechnology, Inc., catalog number sc-9082); STAT1 mAb (Transduction Laboratories, catalog number G16920).
Analysis of gene expression
Total cellular RNA was prepared using the acid phenol method from 9-cm-diameter dishes of confluent cultures of cells treated as indicated and analyzed by RNase protection as described previously using probes for human IFN-␤ and ␥-actin (Goodbourn et al., 1986) . For reporter gene assays, lysates were prepared and analyzed for luciferase and ␤-galactosidase activity as previously described (King and Goodbourn, 1994) .
